Comparison of 24-Hour Electrocardiogram Parameters in Patients with Graves' Disease Before and After Anti-Thyroid Therapy

AKKUŞ G., Sokmen Y., Yilmaz M., Bekler O., AKKUŞ O.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, cilt.21, sa.1, ss.183-191, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.2174/1871530320666200729145100
  • Dergi Adı: ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Biotechnology Research Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.183-191
  • Anahtar Kelimeler: Thyrotoxicosis, arrhythmia, anti-thyroid therapy, Graves' Disease, hyperthyroidism, electrocardiogram, THYROID-HORMONE, PULMONARY-HYPERTENSION, HEART-FAILURE, END INTERVAL, HYPERTHYROIDISM, MANAGEMENT, RISK, DISPERSION, MORTALITY, MANIFESTATIONS
  • Çukurova Üniversitesi Adresli: Evet

Özet

Background: We aimed prospectively to investigate the laboratory and electrocardiographic parameters (heart rate, QRS, QT, QTc, Tpe, Tpe/QTc, and arrhythmia prevalence) in patients with Graves' disease before and after antithyroid therapy.